Tötal Value

Redefining Tötal Value for wound care

Dressing choice is a value decision, not a cost decision

Value based healthcare focuses on the overall value of a wound care pathway rather than the cost of any single product1. It means better patient outcomes can be delivered while using resources more efficiently: fewer dressings, fewer nursing hours and less time in hospital. Learn more with Mölnlycke®, Tötal Value.

Dressing Costs vs Total Cost of Care

Did you know that the largest proportion of cost associated with hard-to-heal (chronic) wound care is the time spent with nurses, general practitioners (GPs) and other healthcare professionals?*

  • 0
    Visits
    Nurses, GPs, other clinicians
  • 0
    Other
    Admissions, tests, medications
  • 0
    Dressings
    The wound care product itself

Unhealed wounds carry most of the burden

Looking at patients by healing status, a small group of unhealed wounds accounts for the majority of total management cost. This is where efficient and effective dressing choice has the biggest impact.

Hard-to-heal (chronic) wounds are a highly prevalent and growing challenge for the healthcare system with their true burden widely underestimated. In a study conducted by Wounds Australia, and reported in their 2024-25 Annual Report, 30% of unhealed wounds equated to 67% of the total cost of wound care treatment in Australia3.  

What are the 3 main cost drivers in wound care?

  • Increased frequency of dressing changes

    More frequent changes mean more nursing time, more materials and more disruption to the wound bed.

  • Protracted healing time

    Wounds that take longer to heal accumulate cost across every visit in the form of additional dressings and additional nursing time.

  • Increased occurrence of complications

    Infections, leakage and periwound skin damage add treatment steps and extend the whole care episode.

Mepilex® Border Flex - Delivering Tötal Value in every Layer

  • With high breathability, the backing film includes dots that allow you to track the progress of the fluid within the dressing.  It also works as a barrier against bacteria particles/ microbes larger than 25nm and is showerproof.  

  • This layer effectively manages both normal and thick wound fluid and traps bacteria.

  • Distributes wound fluid over a wide surface area to maximise the movement of fluid to the retention layer and backing film.

  • Absorbs wound fluid and transfers it to the spreading layer

  • Safetac® Technology minimises pain at dressing changes and reduces the risk of further damage to surrounding new tissue so wounds remain undisturbed to support natural healing.

Tötal Value articles of interest

  • Tötal Value for Procurement

    Seek partnership, not just products, for a strategic mix of high-performing solutions, clinician support and health-economic insights.

  • Tötal Value and high performance

    We help teams measure and drive value through practical, consultative support with a focus on improved wound care performance and sustainable financial savings.

  • Tötal Value with burns dressings

    Burn care is associated with high costs, but it is important to look beyond price-per-unit to consider the total cost of care and cost savings realised by fewer dressing changes, less nursing time required and fewer pain relief medications.

Mepilex® Border Flex can be used by lay persons under supervision of Healthcare Professionals (HCPs).

ALWAYS READ THE LABEL AND INSTRUCTIONS FOR USE.
IF YOU ARE CONCERNED ABOUT YOUR WOUND CONTACT YOUR HEALTHCARE PROFESSIONAL.

References

    1. Porter ME. What is value in health care? New England Journal Medicine. 2010;363(26):2477-2481.
    2. Adapted from guest JF, Fuller GW, Vowden P. Cohort study evaluating the burden of wounds to the UK’s National Health Service in 2017/2018: Update from 2012/2013. BMJ Open. 2020 Dec 22;10(12).
    3. Wounds Australia. Annual report 2024-25. Camberwell (VIC): Wounds Australia; 2024. p. 12. Available from: https://woundsaustralia.org/int/woundsaus/uploads/Publications/Annual%20Reports/wounds%20australia%20annual%20report%202024-25.pdf
    4. Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016;13(Suppl 2):5-15.

Select country

Get knowledge, learn about our products, get support and more.

Australia

No markets

Find jobs, our financial reports and more.

Mölnlycke corporate